Search

Search Constraints

You searched for: Author/Creator Pozzo, Federico

Search Results

1. ARHGDIA, a mutant TP53‐associated Rho GDP dissociation inhibitor, is over‐expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells. (14th February 2013)

2. Clinical significance of c.7544‐7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia. (20th November 2012)

3. COVID‐19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients. Issue 5 (30th August 2021)

4. Elastin MIcrofibriL INterfacer1 (EMILIN‐1) is an alternative prosurvival VLA‐4 ligand in chronic lymphocytic leukemia. Issue 2 (22nd November 2021)

5. NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types. (12th July 2017)

6. TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?. Issue 4 (4th April 2023)